DMAC - DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript
2025-08-13 11:36:21 ET
DiaMedica Therapeutics Inc. (DMAC)
Q2 2025 Earnings Conference Call
August 13, 2025, 8:00 AM ET
Company Participants
Dietrich John Pauls - President, CEO & Director
Julie Krop - Chief Medical Officer
Scott Kellen - CFO & Corporate Secretary
Conference Call Participants
Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division
Thomas Flaten - Lake Street Capital Markets, LLC, Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q2 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section. Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Statement Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica's most recent annual report on Form 10-K and most recent quarterly report on Form 10-Q....
DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript